Multidrug-Resistant Corynebacterium striatum Developed During Treatment of Ommaya Reservoir Infection
Tomonori Kurimoto,Yoshiaki Cho,Takashi Matsuoka
DOI: https://doi.org/10.2147/IMCRJ.S361505
2022-05-03
International Medical Case Reports Journal
Abstract:Tomonori Kurimoto, Yoshiaki Cho, Takashi Matsuoka Department of Pediatrics, Okinawa Prefectural Nanbu Medical Center and Children's Medical Center, Okinawa, 901-1193, Japan Correspondence: Tomonori Kurimoto, Okinawa Prefectural Nanbu Medical Center and Children's Medical Center, 118-1, Shinkawa, Haebaru-cho, Shimajiri-gun, Okinawa, 901-1193, Japan, Tel +81-98-888-0123, Fax +81-98-888-6400, Email Corynebacterium striatum , a common component of the skin and mucosal microbiota of both immunocompetent and immunocompromised individuals, has become an emerging pathogen, colonizing indwelling medical devices and causing infections at multiple sites. A 3-year-old boy with an Ommaya reservoir in the right ventricle and a medical history of grade 3 intraventricular hemorrhage, Hirschsprung disease, catheter-related methicillin-resistant Staphylococcus aureus bacteremia, and congenital central hypoventilation syndrome was hospitalized for Ommaya reservoir infection with C. striatum . He was treated with ampicillin, to which the initial isolate was susceptible. C. striatum may have acquired multiple-drug resistance during the antibiotic treatment due to biofilm production. The Ommaya reservoir was replaced by external ventricular drainage. Cultures of the removed Ommaya reservoir, and cerebrospinal fluid samples grew C. striatum , which was susceptible to meropenem and vancomycin and resistant to other antibiotics. The antibiotic was switched to vancomycin to treat this new multidrug-resistant strain. After 8 days of vancomycin treatment, the cerebrospinal fluid culture obtained by a lumbar puncture was negative for C. striatum . In cases of device-associated infections caused by biofilm-producing bacteria, it is desirable to remove the device as soon as possible. Keywords: coryneform bacterium, biofilm, antibiotic resistant, vancomycin Corynebacterium striatum is a coryneform bacterium occasionally isolated in clinical microbiology laboratories. It is a common component of the skin and mucosal microbiota of immunocompetent and immunocompromised individuals. Little is known about the pathogenic role of C. striatum as it has long been considered a skin contaminant with little or no pathogenic potential. 1 Using new analytical tests such as matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS), suspicious isolates of infection, routinely isolated from patient samples of skin and mucosa and considered contaminants before, are now routinely identified to the species level. Organisms deemed clinically significant include C. striatum in multiple sites. These results portray C. striatum as an emerging pathogen in multiple infection sites and a colonizer of indwelling medical devices. 2 Moreover, C. striatum strains capable of forming biofilm may be selected under antibiotic pressure and develop antibiotic resistance. Conversely, C. striatum may acquire resistance to multiple drugs within biofilm-producing populations. 3 There are no international guidelines for managing infections associated with the Ommaya reservoir. To the best of our knowledge, we report the first pediatric case of multidrug-resistant C. striatum developed during the treatment of Ommaya reservoir infection. A 3-year-old boy with an Ommaya reservoir in his right ventricle presented to our hospital with a fever. The reservoir was used to prevent hydrocephalus after a ventriculoperitoneal (VP) shunt removal placed after a grade 3 intraventricular hemorrhage. He also had a right subclavian portal catheter placed 2 years previously due to Hirschsprung disease (entire colon type). He had a history of catheter-related methicillin-resistant Staphylococcus aureus (MRSA) bacteremia. He was mechanically ventilated through a tracheostomy because of congenital central hypoventilation syndrome. On examination, he had a fever of 38.8°C and erythema around the Ommaya reservoir. Hematology showed a white blood cell count of 9260 cells/mL with 50% neutrophils. Cerebrospinal fluid (CSF) from the Ommaya reservoir showed a leukocyte count of 6 cells/mL (40% neutrophils and 60% lymphocytes) and Gram-positive bacilli on Gram stain. Empiric intravenous treatment was initiated with 300 mg/kg/day of cefotaxime for Ommaya reservoir infection. After 3 days of cefotaxime treatment, his fever persisted. Therefore, considering the patient's history of catheter-associated MRSA bacteremia, two sets of blood cultures were drawn, one from a peripheral site and another from the indwelling vascular catheter. A second CSF sample from the Ommaya reservoir was obtained, and antibiotic treatment was switched from cefotaxime to vancomycin (20 mg/kg/day) and meropenem (120 mg/kg/day). The CSF from the -Abstract Truncated-